ahlam1399
09-23-2016, 12:36 AM
Lundbeck says Alzheimer?s drug fails in late-stage study
(Reuters) - Danish drugmaker H Lundbeck A/S's highly anticipated experimental Alzheimer's drug failed in a late-stage study, underscoring the challenges faced by drugmakers to tackle the debilitating memory-robbing disease.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=GRoOsvJzSVY:IZXCMhtK-VE:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=GRoOsvJzSVY:IZXCMhtK-VE:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=GRoOsvJzSVY:IZXCMhtK-VE:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=GRoOsvJzSVY:IZXCMhtK-VE:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=GRoOsvJzSVY:IZXCMhtK-VE:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/GRoOsvJzSVY
(Reuters) - Danish drugmaker H Lundbeck A/S's highly anticipated experimental Alzheimer's drug failed in a late-stage study, underscoring the challenges faced by drugmakers to tackle the debilitating memory-robbing disease.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=GRoOsvJzSVY:IZXCMhtK-VE:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=GRoOsvJzSVY:IZXCMhtK-VE:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=GRoOsvJzSVY:IZXCMhtK-VE:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=GRoOsvJzSVY:IZXCMhtK-VE:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=GRoOsvJzSVY:IZXCMhtK-VE:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/GRoOsvJzSVY